mRNA Coronavirus Disease 2019 Vaccine-Associated Myopericarditis in Adolescents: A Survey Study.
The Journal of pediatrics
In this survey study of institutions across the US, marked variability in evaluation, treatment, and follow-up of adolescents 12 through 18 years of age with mRNA coronavirus disease 2019 (COVID-19) vaccine-associated myopericarditis was noted. Only one adolescent with life-threatening complications was reported, with no deaths at any of the participating institutions.
Kohli U, Desai L, Chowdhury D, Harahsheh AS, Yonts AB, Ansong A, et al [Freij BJ], mRNA coronavirus disease 2019 vaccine-associated myopericarditis in adolescents: a survey study. J Pediatr. 2022 Apr;243:208-213.e3. doi: 10.1016/j.jpeds.2021.12.025. PMID: 34952008